Lux Capital

Lux Capital is a venture capital firm established in 2000, with offices in New York City and Silicon Valley. The firm specializes in founding, seed, early-stage, and growth investments, primarily in the physical and life sciences, as well as sectors such as biochemistry, material science, aerospace, and advanced technologies like machine learning and synthetic biology. Lux Capital actively supports entrepreneurs in developing successful businesses, leveraging its extensive expertise to enhance the connectivity and competitive edge of its portfolio companies. With assets under management totaling approximately $4 billion, the firm has played a significant role in founding over 20 companies, focusing on high-growth opportunities and innovative solutions across diverse industries.

Steve Brody

COO

Herb Goronkin Ph.D

Venture Partner

Grace Isford

Partner

Lan Jiang

Associate, Investments

Alex Nguyen

Partner

Segolene Scarborough

CFO

Shaquille Vayda

Principal

Shaq Vayda

Principal

Josh Wolfe

Co-Founder and Managing Partner

David K. Yang

Investor

413 past transactions

Siren Biotechnology

Seed Round in 2023
Siren Biotechnology is a biotech company focused on developing innovative cancer treatments through a unique gene therapy platform. The company merges two advanced therapeutic technologies: adeno-associated virus (AAV) gene therapy and cytokine immunotherapy. This integrated approach addresses significant challenges in cancer treatment, including drug delivery, efficacy, and toxicity. By combining these methods, Siren Biotechnology aims to enhance the elimination of tumor cells and stimulate anti-tumor immune responses, offering a novel strategy for combating cancer.

Trial Library

Seed Round in 2022
Trial Library is a clinical trials company focused on oncology, dedicated to enhancing health equity through innovative technology. By promoting inclusive research environments, the company aims to improve health outcomes and transform standards of care in cancer treatment. Its technology facilitates equitable recruitment for clinical trials, ensuring broader access to precision medicine for diverse populations. Through these efforts, Trial Library addresses existing inequities in cancer research and care, ultimately striving to accelerate advancements in clinical trial participation and outcomes.

Kinetic

Seed Round in 2022
Kinetic is a company operating in stealth mode.

ZEDEDA

Series B in 2022
ZEDEDA specializes in edge virtualization software that enhances visibility, control, and security for IoT edge applications and networks. The company's cloud-native platform enables organizations to monitor and manage real-time edge applications across various hardware configurations, facilitating deployment and integration with any cloud or on-premises systems. This approach allows businesses to maintain complete control over their edge data while avoiding vendor lock-in. ZEDEDA offers solutions such as Edge Quick Connect for Azure IoT Edge, which assists customers in managing and securing their IoT deployments. The company's technology finds applications in sectors including renewable energy, oil and gas automation, and industrial automation. Founded in 2016, ZEDEDA is headquartered in Santa Clara, California, with additional offices in Bengaluru and Pune, India.

Rivet

Series B in 2022
Rivet Health, Inc. is a company specializing in healthcare revenue cycle management through its software-as-a-service platform. Founded in 2018 and based in Cottonwood Heights, Utah, Rivet provides tools that enhance financial transparency and operational efficiency for healthcare providers and patients. Its offerings include features that allow providers to quote and collect patient costs upfront and manage payer contracts effectively. The software also helps patients understand their financial responsibilities, detect underpayments, and create accurate estimates, thereby fostering better communication between providers and payers. By addressing the complexities of healthcare transactions, Rivet aims to improve the overall experience for both patients and providers.

Epsilon3

Series A in 2022
Epsilon3 develops spacecraft operations software aimed at modernizing space missions and establishing a new industry standard for operational software. The company's platform provides interactive, real-time synchronized procedures tailored for various programs and missions. It features detailed analytics, reports, and dashboards that enhance decision-making for satellite operators, space manufacturers, and integrators. By streamlining processes, Epsilon3 helps its clients save time and reduce costs throughout the entire lifecycle of their projects.

Fruitful

Series A in 2022
Fruitful is a financial wellness platform that helps people take more control over their money. Fruitful members receive personalized financial advice from a qualified specialist, hands-on investment management, and access to ultra-high-yield savings.

Anagenex

Series A in 2022
Developer of drug discovery platform designed for radically accelerating small molecule drug discovery and finding pharmaceutical compounds for medically important targets. The company's technology rapidly analyzes compounds by combining machine learning with DNA-encoded libraries to generate enormous amounts of useful data and parallel biochemical experiments using proprietary artificial intelligence (AI) models, enabling researchers to develop new drugs.

Vendia

Series B in 2022
Vendia, Inc. is a San Francisco-based company that offers a cloud and blockchain-based platform designed for serverless and distributed data sharing. Its primary product, Vendia Share, allows users to share data and code in real time with partners while maintaining control over their information. This platform facilitates various applications, including multi-party collaborations, cross-cloud and cross-account data sharing, real-time data analytics for forecasting, and autonomous supply chains to enhance supply and demand predictions. Since its incorporation in 2020, Vendia has focused on enabling seamless data exchange across multiple clouds and organizations.

Miga

Seed Round in 2022
Miga is a virtual cardiometabolic clinic that focuses on improving heart health through an innovative platform that combines gamified mobile applications with comprehensive clinical services. Founded by Jarrad Aguirre, MD, and Dre Limberopoulos, Miga's offerings include at-home monitoring for blood pressure, telemedicine consultations, mail-order pharmacy services, and lifestyle coaching. The clinic addresses various cardiometabolic conditions such as obesity, hypertension, diabetes, and hyperlipidemia, empowering patients to manage their health effectively and reduce the risk of serious heart issues, including premature heart attacks and strokes.

Neptune Mutual

Venture Round in 2022
Neptune Mutual is a developer of a parametric cover platform aimed at protecting user funds from risks associated with cryptocurrency, including exploits related to exchanges, custody providers, and smart contracts. The platform focuses on creating user-centric hedging products on the blockchain, providing investors with tools to mitigate the impact of malicious activities in the digital asset space. By exploring innovative approaches to risk protection, Neptune Mutual seeks to enhance security and confidence among cryptocurrency users.

STORD

Series D in 2022
STORD, Inc. is a technology-driven company that provides a cloud-based software platform for warehousing and distribution services. Founded in 2015 and based in Atlanta, Georgia, STORD enables clients to manage their product flow across a network of over 500 warehouses and 15,000 carriers through a single dashboard. This platform enhances visibility and control over inventory, allowing shippers to optimize their supply chains efficiently. By leveraging data science and a comprehensive logistics network, STORD delivers significant cost savings to major retailers, consumer packaged goods companies, and manufacturers, while improving customer satisfaction. The company’s mission is to facilitate scalable, technology-driven supply chains that can be implemented more quickly and affordably than traditional methods.

Hugging Face

Series C in 2022
Hugging Face is a computer software company that provides a software platform that specializes in conversational artificial intelligence. Its platform focuses on developing research papers on Machine Learning and Natural Language Processing systems. The company was founded in 2016 and headquartered in New York, United States.

Umba

Series A in 2022
umba develops a mobile application for financial services. Its tool calculates credit eligibility of customers. umba was formerly known as Mkopo Kaka. The company was founded in 2017 and is based in Nairobi, Kenya.

Hadrian

Series A in 2022
Hadrian is a manufacturer of critical precision components tailored for the aerospace and defense industries. The company offers a platform that streamlines the production of these components, enabling factories to deliver high-quality parts quickly and efficiently. By focusing on advanced manufacturing techniques, Hadrian aims to significantly reduce the costs associated with building rockets, satellites, engines, and drones. This approach supports frontier technology enterprises in developing innovative aerospace solutions at a more affordable rate, ultimately contributing to advancements in rocket and aircraft manufacturing.

Cloaked

Series A in 2022
Developer of privacy software designed to create unlimited identities and privacy protection for online and travel. The company's platform gives users access to the online platforms they want without the need to give out their personal information like personal emails, phone numbers, and addresses and gives the users active control over how they participate in the digital environment, enabling users to eliminate the pressure to share personal info online and in-person.

Impulse Space

Seed Round in 2022
Impulse Space Propulsion is the developer of in-space transportation services for the inner solar system. Founded in 2021 by Tom Mueller, the company is based in El Segundo, California, United States.

Alife

Series A in 2022
Alife is a health technology company that specializes in developing artificial intelligence tools aimed at improving the success rates of pregnancy for patients undergoing fertility treatments. Founded in 2020 by Paxton Maeder-York and based in San Francisco, California, Alife utilizes advancements in deep learning and software development to assist physicians in selecting the healthiest embryos during in vitro fertilization (IVF) procedures. The company's mission is to connect fertility specialists with patients, ultimately enhancing the chances of having healthy children. Through its innovative approach, Alife seeks to play a significant role in the field of reproductive health.

Ramp

Series C in 2022
Ramp is a technology company based in New York that specializes in corporate credit cards and spending management solutions for businesses and startups. Founded in 2019, Ramp's corporate card offers tools for tracking expenses and gaining insights, alongside cashback rewards for purchases made at various retailers. The company aims to streamline corporate spending by providing higher card limits, automated expense management, and seamless integration with accounting systems. Ramp was founded by the team behind Paribus, known for facilitating automated savings on online purchases. Additionally, Ramp Holdings, an entity with a longer history, focuses on video management and delivery solutions, enabling organizations to optimize video content through advanced search, delivery, and monetization capabilities. Originally established in 1948 and based in Boston, this subsidiary of Raytheon BBN Technologies utilizes innovative technologies such as speech-to-text and natural language processing to enhance video experiences across numerous industries.

Womp

Seed Round in 2022
Womp is an all-in-one platform that leverages artificial intelligence to facilitate the creation of CAD and 3D models, catering specifically to the needs of 3D printing and new media applications such as web 3D, augmented reality, and virtual reality. The company specializes in 3D scanning, modeling, and printing services, enabling users to create physical objects from digital designs. Womp's technology captures the dimensions of an object, transforming it into a 3D mesh file, which can be printed in a variety of sizes and materials. This comprehensive approach allows customers to easily build intuitive and functional physical representations from their digital models.

Creyon

Series A in 2022
Creyon Bio is a pre-clinical stage company focused on advancing drug development through a data-driven methodology. It specializes in engineering RNA-based medicines and their components by creating proprietary datasets that inform advanced machine learning models. This innovative approach enables the rapid identification of design rules and engineering principles necessary for the development of safe and effective oligonucleotide-based medicines. By leveraging these insights, Creyon Bio aims to improve the efficiency of the drug development process, ultimately contributing to cost savings in the healthcare sector while catering to diverse patient populations.

OpenSpace

Series D in 2022
OpenSpace offers photo documentation which is automatically pinned to plan location with AI. It specializes in computer vision and construction. The company was founded in 2017 and is headquartered in San Francisco, California.

Aurora Solar

Series D in 2022
Aurora Solar Inc. is a software company focused on the solar industry, providing a cloud-based platform that supports solar photovoltaic (PV) engineering design, workflow management, and customer acquisition. Founded in 2013 and headquartered in San Francisco, California, the company offers tools that utilize satellite imagery and lidar data to create detailed 3D models of terrains and buildings. This technology allows users to accurately assess rooftop dimensions and slopes, streamlining the planning and installation process for solar panels. Aurora Solar's software is utilized by a diverse range of clients, including independent installers, module manufacturers, and large contractors, enhancing their capabilities in solar design and sales.

Plexium

Series B in 2022
Plexium, Inc. is a biotechnology company based in San Diego, California, established in 2017. The company specializes in drug development, focusing on the identification of small molecules that modulate E3 ligases for therapeutic applications in cancer and neurodegenerative diseases. Plexium employs a DNA-encoded library platform to conduct high-throughput screening, utilizing cell-based assays to discover molecular glues that can alter E3 ligase substrate recognition, thereby inducing, inhibiting, or modulating protein degradation. This innovative approach allows Plexium to selectively target various cancers, including small cell lung and breast tumors, while also exploring mechanisms to enhance immune responses through E3 ligase modulation.

Flutterwave

Series D in 2022
Flutterwave provides a payment service for global merchants and payment service providers. It provides technology, infrastructure, and services to enable global merchants, payment service providers, and helps banks and businesses build secure and seamless payment solutions for their customers by smoothening the exchange of funds. The company was founded in 2016 by Iyinoluwa Aboyeji and Olugbenga Agboola and is headquartered in San Francisco, California.

Kallyope

Series D in 2022
Kallyope Inc. is a biotechnology company based in New York that focuses on the gut-brain axis, the complex communication network between the gastrointestinal tract and the brain. Founded in 2014, Kallyope develops innovative therapeutics and consumer products aimed at enhancing human health and nutrition. The company leverages advanced technologies in sequencing, computational biology, neural imaging, and human genetics to gain insights into gut-brain biology. This understanding allows Kallyope to engage in drug discovery efforts that target the fundamental processes of human physiology, with the potential to transform approaches to health and nutrition.

Neo.Tax

Series A in 2022
Neo.tax is a tax preparation and filing service based in Mountain View, California, that specializes in assisting early-stage startups. The company offers a tax automation platform that employs machine learning algorithms to streamline the collection and organization of data from various sources, including emails, documents, project management tools, and financial systems. This technology generates comprehensive reports that detail all activities, expenses, and methodologies used to claim tax credits. By enhancing accuracy and simplifying the review process, Neo.tax aims to ensure that businesses are audit-ready, thereby facilitating a more efficient and reliable tax filing experience.

Balanced

Seed Round in 2022
Balanced is committed to helping older adults maintain vibrancy in their lives, with an exercise platform that promises community, joy, and a personalized experience.

Mos

Series B in 2022
Mos is a financial services platform designed to simplify the process of accessing government aid and financial assistance for students. Initially focused on college financial aid, Mos has streamlined the application process, allowing users to apply for a significant portion of the available government aid through a single application. The platform provides comprehensive guidance and research on financial sources, helping students navigate the complexities of financial aid and remove barriers to accessing funds. By prioritizing user experience, Mos enables individuals to understand and claim their rights and benefits more effectively.

Parallel Markets

Series A in 2022
Parallel Markets Inc. is an investor identity company that operates an online platform aimed at simplifying the onboarding and verification process for investors. Founded in 2018 and based in New York, the company provides services that authenticate and verify user credentials, allowing investors to share their qualifications across various platforms with a single click. The platform caters to both individual and institutional investors, offering a suite of identity products designed to enhance the efficiency of partner onboarding processes. Additionally, Parallel Markets tokenizes companies and other real assets, facilitating the verification of accredited investors and enabling the seamless signing of deals. This innovative approach supports the public ownership and trading of typically illiquid assets such as companies, funds, real estate, sports teams, and art.

Gandeeva Therapeutics

Series A in 2022
Gandeeva Therapeutics is a biotechnology company focused on drug discovery, utilizing a proprietary platform that integrates cryogenic electron microscopy and machine learning. This platform enables the detailed characterization of protein-drug interactions at the atomic level, facilitating insights into protein function and interactions. The company's approach includes target prediction and validation, hit identification through virtual and fragment library screening, and lead optimization. Gandeeva Therapeutics is developing innovative therapeutics aimed at key protein-protein interactions, particularly in oncology, with a robust preclinical pipeline that addresses challenging cancers using novel protein interaction modulators, such as interfacial glues and allosteric inhibitors. This methodology aims to reduce the risks associated with late-stage clinical failures in drug development.

Epsilon3

Seed Round in 2022
Epsilon3 develops spacecraft operations software aimed at modernizing space missions and establishing a new industry standard for operational software. The company's platform provides interactive, real-time synchronized procedures tailored for various programs and missions. It features detailed analytics, reports, and dashboards that enhance decision-making for satellite operators, space manufacturers, and integrators. By streamlining processes, Epsilon3 helps its clients save time and reduce costs throughout the entire lifecycle of their projects.

Formic

Series A in 2022
At Formic, we want to increase the collective output of humanity by making automation deployments trivial and easy. Every factory should have access to unlimited 'labor' through robotics and automation rentals. We are building technology, financing, operations and services to make this vision possible. Formic is a fast-growing venture-backed startup focused on unlocking robotic automation in labor-starved industries such as food and beverage, advanced manufacturing, consumer packaged goods and other industrial settings. We combine financial innovation with a firm understanding of what robotics are capable of, to enable manufacturing customers to scale up their manufacturing capacity quickly and with minimal risk.

Cloaked

Seed Round in 2022
Developer of privacy software designed to create unlimited identities and privacy protection for online and travel. The company's platform gives users access to the online platforms they want without the need to give out their personal information like personal emails, phone numbers, and addresses and gives the users active control over how they participate in the digital environment, enabling users to eliminate the pressure to share personal info online and in-person.

Ironclad

Series E in 2022
Ironclad, Inc. is a San Francisco-based company founded in 2014 that specializes in contract management software designed for legal teams. Its platform streamlines contract workflows by automating processes such as creation, approvals, and compliance, allowing legal departments to focus on providing strategic advice. Ironclad's software includes features like automated templates for various types of contracts, e-signatures, and the ability to store finalized documents while integrating data entry into other systems. By transforming contract processes for legal, sales, and operations teams, Ironclad enhances the management of contracts as valuable intelligence assets. The platform is utilized by in-house legal teams at notable companies, enabling them to unlock and analyze contract data effectively.

Gameto

Series A in 2022
Gameto is a biotechnology company focused on addressing infertility and menopause-related challenges. Founded in 2020 and headquartered in New York, the firm employs a unique platform that utilizes proprietary combinations of transcription factors to create engineered ovarian cell lines. These cell lines are designed to replicate the functions of natural ovarian cells, allowing for the production and regulation of hormones essential for female reproductive health. By harnessing allogeneic human cellular derivatives, Gameto aims to develop therapeutic applications that can effectively treat conditions associated with accelerated ovarian aging and enhance assisted fertility options for women.

Eikon Therapeutics

Series B in 2022
Eikon Therapeutics is a biopharmaceutical company focused on developing innovative treatments for chronic and life-threatening diseases. Founded in 2019 and based in Hayward, California, the company utilizes advanced super-resolution microscopy technology to conduct live-cell and single-molecule imaging. This cutting-edge approach allows for real-time, molecular-resolution measurements of protein movement within living cells, enabling the identification of previously intractable drug targets. By directly measuring the interactions between chemical compounds and individual proteins in a cellular environment, Eikon Therapeutics aims to unlock new avenues for drug discovery and address complex health challenges.

mPharma

Funding Round in 2022
mPharma Data, Inc. is a technology-driven company based in Accra, Ghana, with an additional location in Lexington, Massachusetts. Founded in 2013, it focuses on improving access to high-quality medications in emerging markets by connecting physicians, pharmacies, and patients through its application. The company aggregates real-time market data on prescription trends, drug consumption, and adverse reactions, providing valuable insights to pharmaceutical manufacturers, distributors, and governments. mPharma offers a pharmacy network application that centralizes inventories from multiple pharmacies, enabling easier drug searches for physicians and patients. Additionally, the company provides subscription-based data analytics for actionable insights on drug consumption and diagnosis, along with prescription management tools to assist healthcare providers in locating various medicines. By partnering with drug manufacturers, insurance companies, and governments, mPharma aims to facilitate affordable access to essential medications for patients.

Anagenex

Seed Round in 2022
Developer of drug discovery platform designed for radically accelerating small molecule drug discovery and finding pharmaceutical compounds for medically important targets. The company's technology rapidly analyzes compounds by combining machine learning with DNA-encoded libraries to generate enormous amounts of useful data and parallel biochemical experiments using proprietary artificial intelligence (AI) models, enabling researchers to develop new drugs.

Anchorage

Series D in 2021
Anchorage is a crypto-native Qualified Custodian catering to institutional investors, providing a secure platform for trading, staking, and governance of digital assets. Founded in 2017 by former security engineers from Square and Docker, the company is headquartered in San Francisco, California. Anchorage has developed a regulated platform that emphasizes security and usability, facilitating simple participation in digital assets while ensuring robust custody solutions. The firm has attracted significant funding from prominent investors and serves a clientele that includes many of the largest and most recognized names in the cryptocurrency industry, positioning itself as a leader in the space.

Perchwell

Series A in 2021
Perchwell is a fully integrated online residential real estate search and collaboration product.

Nomic

Series A in 2021
Nplex Biosciences is a biotechnology company based in the United States that specializes in proteomic technology. The company has developed a platform that utilizes DNA nanotechnology to understand, detect, and treat diseases. Nplex offers a range of instruments and automation tools for measuring multiple proteins from blood samples, providing cost-effective solutions for protein data analysis. Its technology integrates seamlessly with industry-standard cytometers, enabling high-throughput analysis and the development of custom protein panels. Nplex aims to enhance existing instruments and workflows while facilitating automation in proteomic research and applications.

Buf

Series B in 2021
Buf Technologies, Inc. is a technology company based in Buffalo, New York, founded in 2020. It specializes in protocol buffer technology, which simplifies the use of client-independent protocols for organizations. Buf offers an API tool that includes a linter to promote effective API design, a detector for breaking changes to maintain compatibility, and a configurable file builder for creating images. This technology alleviates the need for companies to reinvent mechanisms for serializing structured data, allowing them to manage various protocols efficiently. By prioritizing compatibility and design compliance, Buf enables clients to concentrate on their core business functions.

H1.co

Series C in 2021
H1 is the developer of a healthcare data analytics platform intended to help companies make smarter scientific decisions. The company specializes in providing real-time data to support the end-to-end therapeutic development process from fundraising to product development to product launch, thereby providing the healthcare industry, organizations, and professionals with on-demand, live insights from across the data universe to accelerate the discovery and development of therapies to fight diseases.

Applied Intuition

Series D in 2021
Applied Intuition, Inc. specializes in providing software infrastructure for the safe development, testing, and deployment of autonomous vehicles at scale. Founded in 2017 and headquartered in Sunnyvale, California, the company has established a strong presence with additional offices in Detroit, Tokyo, and Munich. Its product suite emphasizes simulation and analytics, offering advanced tools that enable automotive companies to conduct comprehensive testing and accelerate the development of autonomous technologies. With a team comprised of experts from leading firms in the technology and automotive sectors, Applied Intuition supports a diverse range of clients in enhancing their autonomous vehicle initiatives.

Archive

Seed Round in 2021
Archive automates e-commerce digital marketing workflows with two products: (1) Archive App (AA) is a digital asset manager built for modern digital marketers. App automates the collection and metadata labeling of all your brand's social content (including ephemeral stories) and automates the workflow to convert and distribute this content as optimized advertising creative across your favorite retention marketing and media platforms. (2) Archive Communities (AC) automates a brand's influencer seeding program to drive impressions and generate affiliates.

Shiru

Series A in 2021
Shiru, Inc., a food technology company, develops and produces proteins. The company focuses on producing edible proteins to replace dairy products and eggs in the food industry. Shiru, Inc. was incorporated in 2019 and is based in Oakland, California.

Bild

Seed Round in 2021
Bild is an on-demand manufacturing platform that provides companies access to quick-turn prototyping manufacturers. Through the platform, users will also have access to the tools needed to efficiently engage and manage designs with manufacturing partners, enabling them to prototype faster and get to validation earlier.

Saildrone

Series C in 2021
Saildrone, Inc. specializes in the design and manufacture of autonomous sailing drones powered by wind and solar energy, enabling efficient and cost-effective ocean data collection. Founded in 2012 and based in Alameda, California, the company operates a fleet of these drones to gather live ocean data for various applications, including weather forecasting, oceanography, climate research, fish stock analysis, and environmental monitoring. By providing comprehensive data, Saildrone supports governments and private entities in addressing ecological challenges and enhancing understanding of planetary systems. The company aims to build the world's largest high-resolution ocean datasets, contributing to improved insights in areas such as climate change and carbon cycling.

Saildrone

Series C in 2021
Saildrone, Inc. specializes in the design and manufacture of autonomous sailing drones powered by wind and solar energy, enabling efficient and cost-effective ocean data collection. Founded in 2012 and based in Alameda, California, the company operates a fleet of these drones to gather live ocean data for various applications, including weather forecasting, oceanography, climate research, fish stock analysis, and environmental monitoring. By providing comprehensive data, Saildrone supports governments and private entities in addressing ecological challenges and enhancing understanding of planetary systems. The company aims to build the world's largest high-resolution ocean datasets, contributing to improved insights in areas such as climate change and carbon cycling.

Clarifai

Series C in 2021
Clarifai, Inc. specializes in advanced image recognition systems that enable users to detect near-duplicates and conduct visual searches. Founded in 2013 and headquartered in New York, the company offers a platform that employs machine learning to identify various categories, objects, and tags in images. This technology allows clients to locate similar images within large, uncategorized repositories by leveraging both semantic and visual similarities. Additionally, Clarifai provides a labeling tool called Labeler, which facilitates the organization of datasets, AI-driven data searches, and the training and scaling of AI models in production environments. The company also has an office in Tallinn, Estonia.

Replai

Seed Round in 2021
Replai is a technology company based in Porto, Portugal, founded in 2019, that specializes in creating a platform for generating short esports videos using artificial intelligence. The platform connects to live streams to automatically generate highlights, calculate sponsor value, and adapt content for different audiences. By leveraging AI algorithms, Replai enables esports organizations to enhance fan engagement and loyalty through personalized storytelling and custom-made video clips. The company's innovative approach supports mobile companies in developing effective marketing strategies by providing creative intelligence that elevates their brand presence within the esports community.

Science 37

Post in 2021
Science 37, Inc. is a technology-driven clinical trial company focused on transforming clinical research through patient-centric models. It has developed NORA (Network Oriented Research Assistant), a cloud-based mobile research platform that facilitates communication between researchers and patients via videos, photographs, and surveys, enabling end-to-end networked clinical trial services. The company also offers the Science 37 Metasite, which enhances access to diverse patient populations for clinical studies, and the Science 37 Platform for decentralized clinical trials. By utilizing its virtual model, Science 37 has demonstrated faster enrollment and higher patient retention, reaching a broader and more representative patient demographic than traditional site-based research. The company serves a wide range of clients, including large pharmaceutical firms, biotechnology companies, universities, and startups. Since its incorporation in 2014, Science 37 has established itself as a leader in virtual clinical trials, leveraging an extensive network of telemedicine investigators and home-health nurses to conduct more decentralized interventional trials than any other organization.

Chronosphere

Series C in 2021
Chronosphere, Inc. develops an open-source metric data platform known as M3, designed for monitoring cloud-native infrastructure. M3 facilitates the monitoring of various components, including containers, virtual machines, physical servers, and network switches, while also providing insights into application performance, particularly in microservices and their interdependencies. Founded in 2019 and headquartered in New York, the company has additional offices in Seattle, Vilnius, and Warsaw. Chronosphere aims to redefine monitoring in the cloud-native environment by offering a scalable, reliable, and cost-efficient platform. The company's product is rooted in a metrics engine developed and open-sourced by its founding team during their tenure at Uber. With over $55 million in funding, Chronosphere is backed by prominent venture capital firms, including Greylock, Lux Capital, and General Atlantic.

Kingdom Supercultures

Series A in 2021
Kingdom Supercultures specializes in developing and producing microbial cultures that assist food manufacturers in creating innovative food products. Founded in 2019 and based in Brooklyn, New York, the company is known for its production of Koji, a traditional Japanese ingredient essential for making miso, sake, and soy sauce, among other applications. In addition to Koji, Kingdom Supercultures offers a range of functional ingredients and biopreservatives, contributing to the production of fermented sodas, beers, and plant-based dairy alternatives. Their unique platform utilizes software and hardware automation to explore the extensive microbial diversity found in nature, enabling the discovery and assembly of new microbial food strains into cultures. This approach supports brands in their efforts to develop healthy and sustainable food options without resorting to synthetic engineering.

Copia

Series A in 2021
Copia specializes in providing advanced tools for industrial automation, focusing on enhancing visibility and control for automation and control engineers. Its flagship product offers Git-based source control specifically designed for programmable logic controller (PLC) programming, which facilitates robust version control and change visibility. By streamlining processes related to quality control and production management, Copia's solutions enable clients to improve operational efficiency, minimize downtime, and manage potential crises proactively. The company's innovative approach aims to transform the industrial landscape through modern technology tailored for fund managers and administrators.

Formic

Seed Round in 2021
At Formic, we want to increase the collective output of humanity by making automation deployments trivial and easy. Every factory should have access to unlimited 'labor' through robotics and automation rentals. We are building technology, financing, operations and services to make this vision possible. Formic is a fast-growing venture-backed startup focused on unlocking robotic automation in labor-starved industries such as food and beverage, advanced manufacturing, consumer packaged goods and other industrial settings. We combine financial innovation with a firm understanding of what robotics are capable of, to enable manufacturing customers to scale up their manufacturing capacity quickly and with minimal risk.

Shapeways

Post in 2021
Shapeways, Inc. operates a 3D printing marketplace that allows users to create, buy, and sell custom products across various categories, including art, fashion, home goods, gadgets, games, jewelry, and miniatures. Founded in 2008 and headquartered in New York, with additional offices in Eindhoven and Seattle, the company emphasizes on-demand printing, ensuring that each order is personalized and tailored to individual needs. By providing access to advanced 3D printing technology, Shapeways fosters a community where members can share their designs and launch businesses globally. Its platform aims to make product design more accessible and inspiring, effectively democratizing the creation process.

Pager

Series C in 2021
Pager, Inc. is a digital health technology company that operates an on-demand service platform, connecting patients with healthcare services in various settings, including their homes and workplaces. The company offers a mobile application that addresses urgent care needs, such as infections, allergies, and other health concerns. Pager provides a comprehensive suite of services, including teleconsultations, nurse chat, vaccination, prescription delivery, and aftercare support. Its platform is designed for payers, providers, and employers, facilitating quick and convenient access to care while promoting effective navigation through the healthcare system. Pager's technology enables seamless communication via chat, voice, and video, and integrates artificial intelligence and data tools to enhance collaboration among healthcare teams. Serving approximately 10 million covered lives across the United States and parts of Latin America, Pager aims to deliver a personalized healthcare experience that simplifies patient interactions with care providers. The company was founded in 2013 and is headquartered in New York.

Statespace

Series C in 2021
StateSpace provides performance analytics and a suite of tools for casual gamers and eSport athletes to maximize their potential. It uses cognitive science and artificial intelligence to revolutionize the way humans improve. Leveraging expertise as neuroscientists, data scientists, video game developers, and computer visionaries, the products bring much needed standardized performance analytics to train. It was founded in 2017 and is headquartered in New York, New York.

Novig

Seed Round in 2021
Novig operates a peer-to-peer sports betting marketplace that allows users to place bets directly against friends or the market without the involvement of traditional sportsbooks. By eliminating the house's cut from the betting process, Novig aims to create a more social and enjoyable betting experience. The platform facilitates users in making bets and tracking their performance, emphasizing a model that prioritizes profitability for its participants. This approach seeks to democratize sports gambling, making it accessible and engaging for a broader audience.

STORD

Series D in 2021
STORD, Inc. is a technology-driven company that provides a cloud-based software platform for warehousing and distribution services. Founded in 2015 and based in Atlanta, Georgia, STORD enables clients to manage their product flow across a network of over 500 warehouses and 15,000 carriers through a single dashboard. This platform enhances visibility and control over inventory, allowing shippers to optimize their supply chains efficiently. By leveraging data science and a comprehensive logistics network, STORD delivers significant cost savings to major retailers, consumer packaged goods companies, and manufacturers, while improving customer satisfaction. The company’s mission is to facilitate scalable, technology-driven supply chains that can be implemented more quickly and affordably than traditional methods.

A-Alpha Bio

Series A in 2021
A-Alpha Bio, Inc., founded in 2017 and based in Seattle, Washington, specializes in synthetic biology with a focus on drug development that targets multiple proteins. The company's flagship platform, AlphaSeq, offers innovative cell-based tools for quantitative and high-throughput measurement of protein interactions. This technology accelerates processes such as target discovery, library screening, and preclinical drug characterization, addressing significant bottlenecks in the industry. By providing biologics and molecular glue discovery and optimization services, A-Alpha Bio supports pharmaceutical companies in enhancing binding and specificity for various target proteins. The team comprises experts in synthetic biology, structural biology, and next-generation sequencing, all dedicated to advancing drug discovery methodologies.

Flora

Seed Round in 2021
We are a Bay Area-based sustainable e-commerce marketplace. We acquiring, nurture and grow e-commerce brands on a mission to make quality, sustainable products more accessible and affordable. Flora exists to empower people to live sustainably in their daily lives because we believe that inspiring small sustainable choices can lead to a big impact.

Atavistik Bio

Series A in 2021
Atavistik Bio is a pre-clinical biotechnology company pioneering the identification of metabolite-protein interactions that have the potential to lead to the discovery and development of first-in-class drug candidates powered by distinct allosteric control mechanisms.

AllStripes

Series B in 2021
AllStripes is a healthcare technology company dedicated to unlocking new treatments for people with rare disease. AllStripes has developed a two-sided platform that empowers patients to access and benefit from their own medical records and generates regulatory-ready evidence for life sciences companies.

Ramp

Series C in 2021
Ramp is a technology company based in New York that specializes in corporate credit cards and spending management solutions for businesses and startups. Founded in 2019, Ramp's corporate card offers tools for tracking expenses and gaining insights, alongside cashback rewards for purchases made at various retailers. The company aims to streamline corporate spending by providing higher card limits, automated expense management, and seamless integration with accounting systems. Ramp was founded by the team behind Paribus, known for facilitating automated savings on online purchases. Additionally, Ramp Holdings, an entity with a longer history, focuses on video management and delivery solutions, enabling organizations to optimize video content through advanced search, delivery, and monetization capabilities. Originally established in 1948 and based in Boston, this subsidiary of Raytheon BBN Technologies utilizes innovative technologies such as speech-to-text and natural language processing to enhance video experiences across numerous industries.

Copia

Seed Round in 2021
Copia specializes in providing advanced tools for industrial automation, focusing on enhancing visibility and control for automation and control engineers. Its flagship product offers Git-based source control specifically designed for programmable logic controller (PLC) programming, which facilitates robust version control and change visibility. By streamlining processes related to quality control and production management, Copia's solutions enable clients to improve operational efficiency, minimize downtime, and manage potential crises proactively. The company's innovative approach aims to transform the industrial landscape through modern technology tailored for fund managers and administrators.

Whisper Aero

Venture Round in 2021
Whisper Aero is a company focused on developing advanced fan and flight technology aimed at reducing noise levels in aviation. By harnessing air more cleanly and efficiently, Whisper Aero seeks to minimize the impact of higher-frequency broadband noise generated by aircraft. The company's innovations are designed to enhance flight experiences while promoting quieter operations, making air travel more environmentally friendly and less disruptive to communities near airports.

Maven

Series D in 2021
Maven Clinic operates an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and postpartum stages. The clinic provides access to video appointments and private messaging with a network of women's and family health practitioners. Its services cover various needs, including IVF, egg freezing, pregnancy, postpartum support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and tailored training for human resources. The company serves individuals, employers, and healthcare professionals, aiming to enhance healthcare experiences and outcomes for families. Founded in 2014 and headquartered in New York City, Maven Clinic is dedicated to delivering accessible and comprehensive care solutions.

Mahana Therapeutics

Series B in 2021
Mahana Therapeutics, Inc. develops an application for treating patients suffering from gastrointestinal (GI) diseases and conditions. The company offers Parallel, a clinically-validated and minimal-contact digital program for people with irritable bowel syndrome (IBS). Mahana Therapeutics, Inc. was formerly known as Mahana Health, Inc. and changed its name to Mahana Therapeutics, Inc. in July 2019. The company was incorporated in 2018 and is based in San Francisco, California. It has an additional location in London, United Kingdom.

Ahana

Series A in 2021
Ahana, founded in 2020 and located in San Mateo, California, specializes in PrestoDB-based ad hoc analytics solutions. As the first company to focus on bringing these offerings to market, Ahana aims to simplify ad hoc analytics for organizations of various sizes. The company's mission includes fostering growth and supporting the Presto community, which is already in extensive use by major internet companies. Ahana operates as a fully remote organization, reflecting its commitment to flexibility and modern workplace practices.

DoNotPay

Series B in 2021
DoNotPay, Inc. is a technology company that provides a platform for legal information and self-help through its chatbot application. Founded in 2015 and based in San Francisco, California, DoNotPay assists users in navigating various legal matters, including filing lawsuits, claiming awards, and contesting bureaucratic issues. The application is available to residents in the United States, Puerto Rico, and the United Kingdom, and it offers services such as appealing parking tickets, disputing bank fees, and helping users claim asylum in the U.S., U.K., and Canada at no cost. By leveraging artificial intelligence, DoNotPay aims to democratize access to legal resources and empower individuals to resolve small claims and other judicial matters efficiently.

HiHello

Series A in 2021
HiHello, Inc. is a software company based in Palo Alto, California, founded in 2018. The company specializes in a digital solution that facilitates the sharing of contact information through personalized digital business cards. Its application allows users to share their contact details via code, text message, or email, catering to both professional and personal networks. Additionally, HiHello's platform offers features such as scanning paper business cards and maintaining an up-to-date address book, which aids users in managing and nurturing their business relationships effectively. By optimizing how individuals connect, HiHello aims to enhance networking opportunities and foster mutually beneficial relationships among users.

Matterport

Post in 2021
Matterport is a technology company that operates a cloud-based platform designed to create 3D and virtual reality models of real-world spaces. Founded in 2011 and headquartered in Sunnyvale, California, the company enables users to capture, modify, and share digital representations of environments through its proprietary 3D camera, which captures both visual and spatial data. The platform includes Matterport Cloud for hosting and processing, as well as tools such as Matterport Spaces and a web-based 3D player that allow users to navigate and visualize these models. Matterport's offerings facilitate immersive experiences in various applications, including real estate and architecture, allowing users to explore and interact with multi-dimensional spaces online.

Traba

Seed Round in 2021
Traba is a marketplace that connects light industrial workers with businesses to fill open shifts. Their focus is on opportunities in warehousing, distribution, and event staffing.

Carbon Health

Series D in 2021
Carbon Health is a tech-enabled healthcare company founded in 2015 and headquartered in San Francisco, California. It provides a mobile application that facilitates primary care services, allowing users to manage their treatment plans, prescriptions, and lab reports in one place. The company offers omnichannel care through various access points, including clinics, pop-up sites, video consultations, and its application, ensuring convenient and accessible healthcare for patients. Additionally, Carbon Health developed a coronavirus assessment tool and has established COVID-19 testing sites in California, further enhancing its commitment to delivering comprehensive healthcare services.

Varda

Series A in 2021
Varda Space Industries, Inc. is a space manufacturing startup founded in 2020 and based in San Francisco, California. The company focuses on creating products in space that can be utilized for terrestrial applications, leveraging the advantages of low gravity. Varda aims to establish an infrastructure that facilitates the harvesting of materials from space, particularly through asteroid mining, to produce new products. The founders of the company are Delian Asparouhov and Trae Stephens.

Genvid Technologies

Series C in 2021
Genvid Technologies develops innovative software tools for interactive streaming specifically tailored for the eSports industry. Founded in 2016 and based in New York City, the company focuses on providing a unique streaming engine that integrates seamlessly with game engines, allowing game developers and broadcasting companies to enhance the viewer experience. Genvid's technology enables users to create custom camera angles, develop interactive viewer interfaces, and analyze player statistics in real-time. By offering a software development kit (SDK), the company empowers game developers to integrate its tools into their games, facilitating premium interactive broadcasts across multiple streaming platforms.

Tendo

Series B in 2021
Tendo Technologies Limited, founded in 2018 and based in London, develops innovative software aimed at enhancing economic security for frontline employees, particularly in the healthcare sector. The company's platform allows users to maintain a portable record of their work, including skills and hours worked, facilitating better management of workforce training and retention. By focusing on the integration of healthcare experiences, Tendo aims to improve clinical outcomes and operational efficiency for patients, clinicians, and caregivers alike. Their cloud-native and configurable solution streamlines workflows, enabling healthcare professionals to dedicate more time to patient care and less to administrative tasks. Through these efforts, Tendo aspires to create a more connected, efficient, and user-friendly healthcare environment.

Primer

Series C in 2021
Primer Technologies, Inc. specializes in developing advanced software that employs machine learning and natural language processing to analyze extensive datasets. The company's platform is designed to read and interpret documents in multiple languages, uncover insights, and generate automated reports that rival human analysis. By facilitating the understanding of vast amounts of text data, Primer assists governments and corporations in monitoring and making sense of global information. Founded in 2015 and headquartered in San Francisco, California, Primer aims to bridge the intelligence gap for businesses and enhance their ability to respond to emerging trends in the world.

Enveda Biosciences

Series A in 2021
Enveda Therapeutics is constructing and decoding the largest integrated dataset of anthropological, biological, and chemical information from medicinal plants to inspire new medicines.

Anduril Industries

Series D in 2021
Anduril Industries is a defense product company that builds technology for military agencies and border surveillance. Anduril commits top technical talent to solving the most complex national security challenges. We’re building the next generation of technology that will aid and protect those who serve on the front lines defending the nation and its interests. Our mission is to develop cutting edge technology that enables America and its allies to maintain global leadership now and into the future.

Fiddler

Series B in 2021
Fiddler Labs, Inc. is a company that specializes in developing an artificial intelligence platform designed to help businesses analyze, manage, and deploy their machine learning models effectively. Founded in 2018 and headquartered in Palo Alto, California, Fiddler offers an Explainable AI Engine that promotes transparency and understanding in AI solutions. This platform allows users across data science, product, and business teams to comprehend, validate, and manage their AI implementations, ensuring that these systems deliver reliable and trustworthy experiences for end-users. By providing statistical metrics, performance monitoring, and centralized controls, Fiddler aims to make AI more accessible and trustworthy for enterprises, ultimately unlocking the complexities of AI and enhancing user confidence in its applications.

Strateos

Series B in 2021
Strateos operates a robotic cloud laboratory that automates chemistry, biology, and tissue analysis to enhance drug discovery processes. By integrating advanced robotics, control systems, and sophisticated imaging and analytics software, Strateos allows pharmaceutical companies to discover new drug candidates more efficiently. The company emerged from a merger between Transcriptic, known for its pioneering robotic cloud laboratory platform, and 3Scan, which specialized in using automation and machine learning to analyze tissue samples. This combination enables Strateos to provide a comprehensive suite of technologies designed to streamline the drug discovery and early development phases. By transforming life science methodologies into data-driven processes, Strateos aims to create a more efficient and cost-effective approach to scientific research, positioning itself as a valuable partner to biotechnology firms seeking to innovate in the field.

Latch

Post in 2021
Latch is a New York-based company that enhances access management for modern buildings through its innovative keyless entry security systems. The company offers a comprehensive solution that allows property owners to manage all doors within multi-family buildings via a smartphone application. This system also enables residents to grant time-limited access to guests and service providers, improving convenience and security. LatchOS, the software platform developed by the company, operates across North America, serving diverse environments from affordable housing to luxury residential towers. Latch collaborates with a range of real estate developers, from large corporations to local property owners, to improve the living, working, and visiting experiences in various types of buildings.

System

Seed Round in 2021
Developer of value-driven technology software designed to help see and encode statistical relationships. The company's software organizes knowledge and data from silos to discovering information based primarily on measured relationships between things in the world to integrate seamlessly with other parts of the data and information stack, enabling professionals and organizations to see, relate, and solve everything.

System

Series A in 2021
Developer of value-driven technology software designed to help see and encode statistical relationships. The company's software organizes knowledge and data from silos to discovering information based primarily on measured relationships between things in the world to integrate seamlessly with other parts of the data and information stack, enabling professionals and organizations to see, relate, and solve everything.

Dyno Therapeutics

Series A in 2021
Dyno Therapeutics Inc. specializes in the development of adeno-associated virus (AAV) vectors for in vivo delivery of gene therapies. Founded in 2018 and based in Cambridge, Massachusetts, the company utilizes an artificial intelligence-driven approach that integrates DNA synthesis, sequencing, and machine learning. This innovative methodology enables the design of novel gene vectors with an emphasis on cell-targeting capsid proteins derived from AAV, which is recognized as the most commonly used vector in gene therapy applications. By leveraging quantitative high-throughput in vivo experimentation, Dyno Therapeutics aims to enhance the effectiveness and precision of gene therapy solutions.

Eikon Therapeutics

Series A in 2021
Eikon Therapeutics is a biopharmaceutical company focused on developing innovative treatments for chronic and life-threatening diseases. Founded in 2019 and based in Hayward, California, the company utilizes advanced super-resolution microscopy technology to conduct live-cell and single-molecule imaging. This cutting-edge approach allows for real-time, molecular-resolution measurements of protein movement within living cells, enabling the identification of previously intractable drug targets. By directly measuring the interactions between chemical compounds and individual proteins in a cellular environment, Eikon Therapeutics aims to unlock new avenues for drug discovery and address complex health challenges.

Pawp

Series A in 2021
Pawp, Inc. is a pet care service provider that offers an online platform designed to assist pet owners in managing their pets' health and accessing veterinary care. Founded in 2018 and based in New York, the company provides users with unlimited 24/7 access to licensed veterinarians, significantly reducing the need for unnecessary vet visits. Pawp also offers a pet emergency fund of $3,000 per year, which serves as a financial safety net for unexpected veterinary expenses. By combining veterinary access with emergency funding, Pawp aims to make pet care more affordable and accessible, allowing pet owners to make informed health decisions for their animals.

Alife

Seed Round in 2021
Alife is a health technology company that specializes in developing artificial intelligence tools aimed at improving the success rates of pregnancy for patients undergoing fertility treatments. Founded in 2020 by Paxton Maeder-York and based in San Francisco, California, Alife utilizes advancements in deep learning and software development to assist physicians in selecting the healthiest embryos during in vitro fertilization (IVF) procedures. The company's mission is to connect fertility specialists with patients, ultimately enhancing the chances of having healthy children. Through its innovative approach, Alife seeks to play a significant role in the field of reproductive health.

OpenSpace

Series C in 2021
OpenSpace offers photo documentation which is automatically pinned to plan location with AI. It specializes in computer vision and construction. The company was founded in 2017 and is headquartered in San Francisco, California.

Higharc

Series A in 2021
Higharc, Inc. is a technology company based in Durham, North Carolina, specializing in a three-dimensional home design and customization platform tailored for new homebuyers and builders. Founded in 2018, the company enables users to create personalized home designs that align with their needs and budget, all displayed in 3D for their specific homesites. Higharc's platform streamlines the homebuilding process by consolidating plans, standards, and options in one location. It also provides accurate materials lists and permit-ready construction documents, enhancing efficiency and reducing material waste. By offering advanced 3D sales tools, Higharc aims to improve the customer experience and support the delivery of better-built homes.

Adyn

Seed Round in 2021
Developer of a birth control optimization test designed to help determine which method of birth control is the best fit for anybody in order to minimize side effects. The company provides medically actionable scientific insights to find the right type of birth control, enabling women to proactively optimize their health-from birth control to fertility, and beyond.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.